Navigation Links
Moderate Exercise Is Good For The Heart: Study

A study on rats has shown that moderate exercise has positive benefits on the hearts, holding out promising implications for humans//.

Several human studies in the last 10 to 20 years have shown that moderate exercise does not appear to harm people suffering from congestive heart failure.

However, the positive benefits of such exercise have not been found to be statistically significant.

In the new study rats carrying the genetic characteristics for spontaneously developing heart failure exercised moderately on a treadmill. They significantly lived longer, the science portal EurekAlert reported.

The exercise protocol, the equivalent of daily, leisurely strolls in humans, extended the life expectancy of the rat study group by at least 10 percent to 15 percent.

"Assuming the results are applicable to humans, low-intensity exercise is likely to have benefits for humans in early stages of congestive heart failure," said Russell Moore, a researcher of the University of Colorado who led the study.

The intensity of exercise in the study was a crucial factor affecting longevity in the rats used in the study, said Moore.

Early in the study, several of the rats that began exercising at nine months of age died after the locomotion speed was increased from 10 metres per minute to 17.5 metres per minute, he said.

The speed was subsequently reduced to 14 metres per minute for the duration of the study, and no additional rat deaths occurred, he said.

"The bottom line is if the animals are exercised too hard, they will die," he said. "But when exercised moderately, in this case at barely more than a walk, the results were striking."

"Our study, coupled with several human studies conducted elsewhere, shows a definite trend indicating that moderate intensity exercise has a potential role in stemming the downward spiral in heart failure," he said.

--IANS
'"/>




Page: 1

Related medicine news :

1. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
2. Moderate alcohol consumption protects against dementia
3. Moderate Exercise may not help prevent Heart Disease
4. The Benefits Of A Diet Consisting Of Moderate Amounts Of Fat
5. Moderate drinking can be good for the kidneys
6. Enjoy Moderate Exercise and Keep Your Heart Fit
7. Even Moderate Drinking Is Not Good For The Heart
8. Moderate Drinkers Found to Escape Obesity and Related Problems
9. Moderate Drinking Can Help Cut Diabetes Risk In Middle-Aged Women
10. Moderate Drinking Does Not Guard Against Heart Disease
11. Children Benefited By Moderate Maternal Stress?
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Moderate Exercise Good For The Heart Study

(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
... to grow rapidly if they are thicker, symmetrical,..., according to a report. In addition, rapidly prog...y men and individuals with fewer moles and freckle... fewer pigments than those of slower-growing cance...
...pecial protein responsible for cell development (N...spread, a new study shows. “Breast cancer cells r...monly used hormonal therapy, by increasing the Not...ator Dr. Lucio Miele, professor, departments of pa...
...ent has proposed insurance cover for each girl chi...irls. Under the scheme, an insurance cover of one ... a safety net and also to enable the girl to recei... Briefing the Members of the Parliamentary Consult...
...dition in which there is involuntary discharge of ...nt quality of life issues and their condition ofte...e American Journal of Gastroenterology highlights ...ng is necessary prior to diagnosis and treatment o...
Other Medicine News:Health News:Characteristics of Fast-Growing Skin Cancers 2Health News:Study Identifies Mechanism Which May Help Tamoxifen Work Better 2Health News:Insurance Cover for Girl Child 2
(Date:9/3/2008)...Australia, Sept. 4 /Xinhua-...aq: PXSL) today announced,that it has enrolled the...nical trial evaluating Bronchitol in cystic fibros...ed in 41 hospitals across North,America, Argentina...e,Pharmaxis seeks approval to market Bronchitol fo...
(Date:9/3/2008)...erm follow up results from chronically infected He...itive data obtained earlier in 2008, - Study is ...long-term antiviral effect of therapeutic H...strongly support move into a second generation, v...) acting through TLR ...
(Date:9/3/2008)...sis showed that Multaq(R) (dronedarone) decreased ...ibrillation or atrial flutter already ...IDGEWATER, N.J., Sept. 3 /-...om the ATHENA study were presented today at,the cl...y of Cardiology,congress 2008, in Munich, Germany....
(Date:9/3/2008)...to be Evaluated in Repeat-Dosing Study in Subjects...FirstCall/ -- Sangamo,BioSciences, Inc. (Nasdaq: ...2 clinical trial (SB-509-801) to evaluate its drug...enerative motor-neuron disease for which there,are...s drug, SB-509, is an injectable formulation of a ...
Breaking Medicine Technology:Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5NFL Themed Milk Touches Down in Schools and Retail Grocery Stores 1555 1NFL Themed Milk Touches Down in Schools and Retail Grocery Stores 1555 2NFL Themed Milk Touches Down in Schools and Retail Grocery Stores 1555 3MAKO Surgical Corp Files Registration Statement for Initial Public Offering of Common Stock 670 1MAKO Surgical Corp Files Registration Statement for Initial Public Offering of Common Stock 670 2The International Diabetes Federation 28IDF 29 Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes 668 1The International Diabetes Federation 28IDF 29 Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes 668 2The International Diabetes Federation 28IDF 29 Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes 668 3Misconceptions about Alzheimers varies among races survey suggests 451 1Misconceptions about Alzheimers varies among races survey suggests 451 2
...NGTON--(BUSINESS WIRE)--May 21, 2007 - Roche today...that all patients who,discontinued treatment with ...n due to adverse events within the first 12 weeks,...PEGASYS(R),(peginterferon alfa-2a) and ribavirin. ...e to go on and complete a full course of,treatment...
...ED DOSE COMBINATION WITH DIURETIC ACCEPTED FOR REV... NJ, 21 May 2007 -,Speedel (SWX: SPPN) today welco...ls of SPP100 (aliskiren, Tekturna/Rasliez[1]),pres...ic Meeting,and Exposition of the American Society ...esults confirm the favourable safety and,efficacy ...
Other Medicine Technology:Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 2Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 3Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 4Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 5Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 6New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 2New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 3New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 4New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 5New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 6New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 7New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 8New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 9New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 10New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 11
Curved left, Hardy Curettes, bayonet, working distance 120 mm, total length 241 mm.
Toothed pituitary rongeur. Straight.
Micro cup pituitary forceps, semi-malleable shafts.
Teardrop dissector. 90, 5 mm.
Medicine Products: